tirzepatide surpass cvot Diabetes Distilled: SURPASS-CVOT – demonstrates cardiovascular benefit in secondary prevention Cardiovascular outcomes of semaglutide and

Studies from Japan have found that these side effects are more frequent with semaglutide compared to medications like sitagliptin [22]

Request current, batch-specific documentation rather than generic certificates

We provide the full spectrum of care-from initial medical assessment and lab review to prescription management and ongoing virtual follow-ups-all through a secure online platform

Pregnant women exposed to these medications and healthcare providers are encouraged to report exposures: For Semaglutide: Contact Novo Nordisk at 1-877-390-2760 or [www.wegovypregnancyregistry.com]( For Tirzepatide: Contact Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) Please note that the above list is not complete, and it describes the most common side effects and risks